Psyence Biomedical
PBM | NASDAQ
$2.83
-$0.31 (-10.02%)
At close: Nov 16, 2026, 4:00 PM ET
$2.83
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-10.02%
(1D)No price chart data available for 1D timeframe.
Rating
13.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1016/1021 (Top 100%)
Key Statistics
Market Data
Market Cap $53.82K
1D Range
2.80 3.13
52W Range
2.23 17.34
Valuation (TTM)
PE -5.55
PB 0.00
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $0.00
Cash Flow
FCF Yield -1957.8%
SBC Adj. FCF Yield -1958.1%
SBC Impact 0.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -34024.4% |
N/A
FCF 3Y | 5Y -55.7% |
N/A
Returns
ROA -39.5%
ROE -58.6%
ROIC -36.8%
Financial Health
Net Cash
$7.2M
Current Ratio 14.62
Interest Coverage -655.06
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment di...
Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Dec 10, 2021
Website www.psyencebiomed.com
Fiscal Year April - March
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PBM